Subscribe to Newsletter
Subspecialties Basic & Translational Research, Retina

Benchmarking Dry AMD

Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries and the third-leading cause in developing countries. Dry AMD, unlike the neovascular, wet form, has no effective therapies available today – bad news, especially as it comprises about 85–90 percent of all AMD cases. Then again, a number of potentially disease-modifying therapies are currently under clinical evaluation, so this situation may change in the future.

In 2015, we benchmarked the PubMed-listed AMD literature as a whole (1), and we’ve also reviewed the entirety of the AMD trial data that’s available on (2). This month, we set out to specifically assess the dry AMD literature.

To provide insight into the past and predictions for the future of the field, a series of metrics were applied to the last five years of published literature.

We asked:

Who has published the most?
Who has had the greatest impact?
What are the big topics
being discussed?
Is this knowledge available online (for free or for a fee)?

PubMed was searched for dry AND “macular degeneration”, with results limited to the last five years, and the data were analyzed in Microsoft Excel 2013.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. M Hillen, “Benchmarking AMD”, The Ophthalmologist, 17, 38–40 (2015). Available at: Accessed January 23, 2017.
  2. M Hillen, R McGuigan, “AMD Clinical Trials”, The Ophthalmologist, 22, 38–40 (2015). Available at: Accessed January 23, 2017.
About the Author
Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as a deputy editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: